04|2026

Transforming Depression Treatment: Andrew Guido’s Journey with TMS

For many dealing with depression, the quest for an effective treatment can feel endless. For Andrew Guido, this struggle was a long-standing part of his life. After years of trying different medications with mixed results, Guido turned to Transcranial Magnetic Stimulation (TMS), and the experience was life-changing. In an interview with The Educated Patient, Andrew… Read more »

04|2026

Evaluating the Efficacy of NeuroStar TMS Therapy  

1. How NeuroStar TMS Works: Targeted Brain Stimulation: NeuroStar TMS uses magnetic pulses to stimulate the prefrontal cortex, a region of the brain involved in mood regulation, which is often underactive in individuals with depression. Neurotransmitter Production: By stimulating brain areas, TMS encourages the release of neurotransmitters like serotonin, dopamine, and norepinephrine, which play a… Read more »

02|2026

Key Information on NeuroStar Advanced TMS Therapy for Adolescents With Major Depressive Disorder  

1. Addressing Seasonal Depression: Healthcare workers in Kanawha County, West Virginia, are focusing on helping individuals with seasonal depression, a condition exacerbated by winter weather and holiday stress. Many people experience worsening depression during this time, with some finding that traditional antidepressants no longer provide relief. 2. NeuroStar TMS as a Solution:    – Non-Invasive… Read more »

10|2025

Clinical Proof – A Scientifically Validated Approach   

Proven Effectiveness: NeuroStar® Advanced Therapy has delivered over 7.1 million treatments, benefiting over 195,000 patients across more than 1,100 practices in the U.S. It is recognized as the market leader in clinical practice for depression treatment. Long-Term Efficacy: NeuroStar has demonstrated long-term effectiveness with established durability for up to 12 months post-treatment. This indicates sustained… Read more »

10|2025

NeuroStar TMS for Teens With Major Depressive Disorder: Exploring the Latest Findings

Main Findings from the Data Presented at the 2024 AACAP Annual Conference on NeuroStar® TMS for Adolescents: 1. High Remission and Response Rates:    – Nearly 60% of adolescents aged 12-19 with Major Depressive Disorder (MDD) achieved remission after treatment with NeuroStar Advanced TMS.    – The remission rate for young adults aged 20-21 was… Read more »